WO2003049700A3 - Growth hormone releasing hormone suplementation for treating chronically ill subjects - Google Patents
Growth hormone releasing hormone suplementation for treating chronically ill subjects Download PDFInfo
- Publication number
- WO2003049700A3 WO2003049700A3 PCT/US2002/039509 US0239509W WO03049700A3 WO 2003049700 A3 WO2003049700 A3 WO 2003049700A3 US 0239509 W US0239509 W US 0239509W WO 03049700 A3 WO03049700 A3 WO 03049700A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- animal
- retarding
- ghrh
- nucleic acid
- growth
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0214869-2A BR0214869A (en) | 2001-12-11 | 2002-12-10 | Plasmid-mediated supplementation for treatment of chronically ill individuals |
EP02804771.0A EP1465654B1 (en) | 2001-12-11 | 2002-12-10 | Plasmid mediated supplementation for treating chronically ill subjects |
CA2469310A CA2469310C (en) | 2001-12-11 | 2002-12-10 | Plasmid mediated supplementation for treating chronically ill subjects |
MXPA04005713A MXPA04005713A (en) | 2001-12-11 | 2002-12-10 | Growth hormone releasing hormone suplementation for treating chronically ill subjects. |
AU2002357143A AU2002357143B2 (en) | 2001-12-11 | 2002-12-10 | Growth hormone releasing hormone supplementation for treating chronically ill subjects |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33961001P | 2001-12-11 | 2001-12-11 | |
US60/339,610 | 2001-12-11 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003049700A2 WO2003049700A2 (en) | 2003-06-19 |
WO2003049700A3 true WO2003049700A3 (en) | 2003-09-18 |
WO2003049700B1 WO2003049700B1 (en) | 2003-10-30 |
Family
ID=23329825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/039509 WO2003049700A2 (en) | 2001-12-11 | 2002-12-10 | Growth hormone releasing hormone suplementation for treating chronically ill subjects |
Country Status (11)
Country | Link |
---|---|
US (2) | US7241744B2 (en) |
EP (1) | EP1465654B1 (en) |
CN (1) | CN1615151A (en) |
AR (1) | AR037778A1 (en) |
AU (1) | AU2002357143B2 (en) |
BR (1) | BR0214869A (en) |
CA (1) | CA2469310C (en) |
MX (1) | MXPA04005713A (en) |
MY (1) | MY142457A (en) |
TW (1) | TW200301778A (en) |
WO (1) | WO2003049700A2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002324909A1 (en) * | 2001-09-07 | 2003-03-24 | Baylor College Of Medicine | Linear dna fragments for gene expression |
MXPA04003944A (en) * | 2001-10-26 | 2004-07-08 | Baylor College Medicine | A composition and method to alter lean body mass and bone properties in a subject. |
EP1465654B1 (en) * | 2001-12-11 | 2015-02-25 | Inovio Pharmaceuticals, Inc. | Plasmid mediated supplementation for treating chronically ill subjects |
US7250405B2 (en) * | 2002-02-07 | 2007-07-31 | Baylor College Of Medicine | Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
EP1513559A4 (en) * | 2002-05-28 | 2006-01-18 | Advisys Inc | Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system |
AU2003295366B2 (en) * | 2002-11-04 | 2011-11-24 | Advisys, Inc. | Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
TW200424214A (en) * | 2003-04-21 | 2004-11-16 | Advisys Inc | Plasmid mediated GHRH supplementation for renal failures |
US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
CA2575926C (en) * | 2003-08-04 | 2014-02-25 | Advisys, Inc. | Canine specific growth hormone releasing hormone |
AU2005269724B2 (en) * | 2004-07-23 | 2011-03-10 | Advisys, Inc. | Growth hormone releasing hormone enhances the immune response induced by vaccination |
US7846720B2 (en) * | 2005-01-26 | 2010-12-07 | Vgx Pharmaceuticals, Inc. | Optimized high yield synthetic plasmids |
RS51324B (en) | 2005-04-25 | 2010-12-31 | Merial Ltd. | Nipah virus vaccines |
JP2009515529A (en) | 2005-11-14 | 2009-04-16 | メリアル リミテッド | Gene therapy for renal failure |
US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
US8980249B2 (en) | 2010-06-03 | 2015-03-17 | University Of Miami | Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets |
WO2012145577A1 (en) | 2011-04-20 | 2012-10-26 | Merial Limited | Adjuvanted rabies vaccine with improved viscosity profile |
US8993316B2 (en) | 2011-11-16 | 2015-03-31 | Brian P. Hanley | Methods and compositions for gene therapy and GHRH therapy |
US9079974B2 (en) * | 2011-12-21 | 2015-07-14 | The University Of Miami | GH-RH analogs with potent agonistic effects |
WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
WO2014100816A2 (en) | 2012-12-21 | 2014-06-26 | University Of Miami | Ghrh agonists for islet cell transplantation and function and the treatment of diabetes |
US9855312B2 (en) | 2012-12-21 | 2018-01-02 | University Of Miami | GHRH agonists for the treatment of ischemic disorders |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5846936A (en) * | 1991-04-09 | 1998-12-08 | Roche Vitamins Inc. | Growth hormone releasing factor analogs |
WO1999005300A2 (en) * | 1997-07-24 | 1999-02-04 | Valentis, Inc. | Ghrh expression system and methods of use |
WO2001006988A2 (en) * | 1999-07-26 | 2001-02-01 | Baylor College Of Medicine | Super-active porcine growth hormone releasing hormone analog |
US6194402B1 (en) * | 1998-09-02 | 2001-02-27 | Merck & Co., Inc. | Enhancement of return to independent living status with a growth hormone secretagogue |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4223020A (en) * | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4223019A (en) | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4226857A (en) * | 1979-03-30 | 1980-10-07 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4228158A (en) | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4224316A (en) | 1979-03-30 | 1980-09-23 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4223021A (en) | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4228156A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4410512A (en) * | 1981-12-28 | 1983-10-18 | Beckman Instruments, Inc. | Combinations having synergistic pituitary growth hormone releasing activity |
NL8200523A (en) | 1982-02-11 | 1983-09-01 | Univ Leiden | METHOD FOR TRANSFORMING IN VITRO PLANT PROTOPLASTS WITH PLASMIDE DNA. |
US5134120A (en) | 1984-08-03 | 1992-07-28 | Cornell Research Foundation, Inc. | Use of growth hormone to enhance porcine weight gain |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5036045A (en) | 1985-09-12 | 1991-07-30 | The University Of Virginia Alumni Patents Foundation | Method for increasing growth hormone secretion |
US4833166A (en) * | 1987-05-01 | 1989-05-23 | Grosvenor Clark E | Growth hormone releasing hormone complementary peptides |
US4839344A (en) | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
USRE33699E (en) | 1987-07-09 | 1991-09-24 | International Minerals & Chemical Corp. | Growth hormone-releasing factor analogs |
FR2622455B1 (en) | 1987-11-04 | 1991-07-12 | Agronomique Inst Nat Rech | APPLICATION OF THE HUMAN GROWTH HORMONE SECRETION STIMULATION FACTOR, ITS ACTIVE FRAGMENTS AND RELATED ANALOGS, TO INCREASE DAIRY PRODUCTION AND NEWBORN WEIGHT IN MAMMALS |
US4952500A (en) * | 1988-02-01 | 1990-08-28 | University Of Georgia Research Foundation, Inc. | Cloning systems for Rhodococcus and related bacteria |
US4956288A (en) | 1988-04-22 | 1990-09-11 | Biogen, Inc. | Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA |
US5023322A (en) | 1988-08-31 | 1991-06-11 | Mta Kutatas-Es Szervezetelemzo Intezete | Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof |
US5084442A (en) | 1988-09-06 | 1992-01-28 | Hoffmann-La Roche Inc. | Cyclic growth hormone releasing factor analogs and method for the manufacture thereof |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5302523A (en) | 1989-06-21 | 1994-04-12 | Zeneca Limited | Transformation of plant cells |
US7705215B1 (en) | 1990-04-17 | 2010-04-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5550318A (en) | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5137872A (en) | 1989-09-18 | 1992-08-11 | Pitman-Moore, Inc. | Growth hormone-releasing factor analogs |
US5322783A (en) | 1989-10-17 | 1994-06-21 | Pioneer Hi-Bred International, Inc. | Soybean transformation by microparticle bombardment |
US5484956A (en) * | 1990-01-22 | 1996-01-16 | Dekalb Genetics Corporation | Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin |
AU656144B2 (en) * | 1990-06-29 | 1995-01-27 | F. Hoffmann-La Roche Ag | Histidine substituted growth hormone releasing factor analogs |
US5486505A (en) | 1990-07-24 | 1996-01-23 | Polygen Holding Corporation | Polypeptide compounds having growth hormone releasing activity |
US5384253A (en) * | 1990-12-28 | 1995-01-24 | Dekalb Genetics Corporation | Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
AU2515992A (en) | 1991-08-20 | 1993-03-16 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
US5610042A (en) * | 1991-10-07 | 1997-03-11 | Ciba-Geigy Corporation | Methods for stable transformation of wheat |
US5298422A (en) * | 1991-11-06 | 1994-03-29 | Baylor College Of Medicine | Myogenic vector systems |
US5925564A (en) * | 1991-11-06 | 1999-07-20 | Baylor College Of Medicine | Expression vector systems and method of use |
JP3368603B2 (en) * | 1992-02-28 | 2003-01-20 | オリンパス光学工業株式会社 | Gene therapy treatment device |
US6033884A (en) | 1992-03-20 | 2000-03-07 | Baylor College Of Medicine | Nucleic acid transporter systems and methods of use |
EP1236473A3 (en) | 1992-04-03 | 2003-01-15 | The Regents Of The University Of California | Self-assembling polynucleotide delivery system |
WO1993023431A1 (en) | 1992-05-14 | 1993-11-25 | Baylor College Of Medicine | Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
US5591616A (en) | 1992-07-07 | 1997-01-07 | Japan Tobacco, Inc. | Method for transforming monocotyledons |
US5702932A (en) * | 1992-07-20 | 1997-12-30 | University Of Florida | Microinjection methods to transform arthropods with exogenous DNA |
EP0652965A1 (en) | 1992-07-27 | 1995-05-17 | Pioneer Hi-Bred International, Inc. | An improved method of agrobacterium-mediated transformation of cultured soybean cells |
DE4228457A1 (en) | 1992-08-27 | 1994-04-28 | Beiersdorf Ag | Production of heterodimeric PDGF-AB using a bicistronic vector system in mammalian cells |
GB9222888D0 (en) | 1992-10-30 | 1992-12-16 | British Tech Group | Tomography |
US5439440A (en) * | 1993-04-01 | 1995-08-08 | Genetronics, Inc. | Electroporation system with voltage control feedback for clinical applications |
US5656610A (en) | 1994-06-21 | 1997-08-12 | University Of Southern California | Producing a protein in a mammal by injection of a DNA-sequence into the tongue |
FR2722208B1 (en) | 1994-07-05 | 1996-10-04 | Inst Nat Sante Rech Med | NEW INTERNAL RIBOSOME ENTRY SITE, VECTOR CONTAINING SAME AND THERAPEUTIC USE |
US5736524A (en) * | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5792747A (en) * | 1995-01-24 | 1998-08-11 | The Administrators Of The Tulane Educational Fund | Highly potent agonists of growth hormone releasing hormone |
WO1996032126A1 (en) * | 1995-04-14 | 1996-10-17 | The Administrators Of The Tulane Educational Fund | Analogs of growth hormone-releasing factor |
US5780448A (en) | 1995-11-07 | 1998-07-14 | Ottawa Civic Hospital Loeb Research | DNA-based vaccination of fish |
US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
US5945100A (en) | 1996-07-31 | 1999-08-31 | Fbp Corporation | Tumor delivery vehicles |
US6251433B1 (en) * | 1996-08-13 | 2001-06-26 | Chiron Corporation | Polycationic polymers |
US5981274A (en) * | 1996-09-18 | 1999-11-09 | Tyrrell; D. Lorne J. | Recombinant hepatitis virus vectors |
US5704908A (en) * | 1996-10-10 | 1998-01-06 | Genetronics, Inc. | Electroporation and iontophoresis catheter with porous balloon |
US5994624A (en) | 1997-10-20 | 1999-11-30 | Cotton Incorporated | In planta method for the production of transgenic plants |
EP1052286A3 (en) * | 1999-04-12 | 2001-07-25 | Pfizer Products Inc. | Growth hormone and growth hormone releasing hormone compositions |
EP1465654B1 (en) * | 2001-12-11 | 2015-02-25 | Inovio Pharmaceuticals, Inc. | Plasmid mediated supplementation for treating chronically ill subjects |
WO2006033679A2 (en) * | 2004-05-25 | 2006-03-30 | Chimeracore, Inc. | Self-assembling nanoparticle drug delivery system |
US9302725B2 (en) | 2013-03-14 | 2016-04-05 | Bell Sports, Inc. | Locking rack system for bicycles |
US9303406B2 (en) | 2014-05-19 | 2016-04-05 | Felix Sorkin | Modified permanent cap |
-
2002
- 2002-12-10 EP EP02804771.0A patent/EP1465654B1/en not_active Expired - Lifetime
- 2002-12-10 US US10/315,907 patent/US7241744B2/en not_active Expired - Lifetime
- 2002-12-10 WO PCT/US2002/039509 patent/WO2003049700A2/en not_active Application Discontinuation
- 2002-12-10 TW TW091135752A patent/TW200301778A/en unknown
- 2002-12-10 MY MYPI20024609A patent/MY142457A/en unknown
- 2002-12-10 MX MXPA04005713A patent/MXPA04005713A/en not_active Application Discontinuation
- 2002-12-10 BR BR0214869-2A patent/BR0214869A/en not_active Application Discontinuation
- 2002-12-10 AR ARP020104785A patent/AR037778A1/en not_active Application Discontinuation
- 2002-12-10 CN CNA02827105XA patent/CN1615151A/en active Pending
- 2002-12-10 AU AU2002357143A patent/AU2002357143B2/en not_active Expired
- 2002-12-10 CA CA2469310A patent/CA2469310C/en not_active Expired - Lifetime
-
2007
- 2007-03-21 US US11/726,291 patent/US8178504B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5846936A (en) * | 1991-04-09 | 1998-12-08 | Roche Vitamins Inc. | Growth hormone releasing factor analogs |
WO1999005300A2 (en) * | 1997-07-24 | 1999-02-04 | Valentis, Inc. | Ghrh expression system and methods of use |
US6194402B1 (en) * | 1998-09-02 | 2001-02-27 | Merck & Co., Inc. | Enhancement of return to independent living status with a growth hormone secretagogue |
WO2001006988A2 (en) * | 1999-07-26 | 2001-02-01 | Baylor College Of Medicine | Super-active porcine growth hormone releasing hormone analog |
US6551996B1 (en) * | 1999-07-26 | 2003-04-22 | Baylor College Of Medicine | Super-active porcine growth hormone releasing hormone analog |
Non-Patent Citations (12)
Also Published As
Publication number | Publication date |
---|---|
BR0214869A (en) | 2005-03-08 |
TW200301778A (en) | 2003-07-16 |
US20090170748A1 (en) | 2009-07-02 |
US20040057941A1 (en) | 2004-03-25 |
WO2003049700B1 (en) | 2003-10-30 |
CN1615151A (en) | 2005-05-11 |
CA2469310C (en) | 2013-01-29 |
AU2002357143B2 (en) | 2009-07-30 |
EP1465654A2 (en) | 2004-10-13 |
CA2469310A1 (en) | 2003-06-19 |
EP1465654A4 (en) | 2007-08-29 |
WO2003049700A2 (en) | 2003-06-19 |
MXPA04005713A (en) | 2005-06-06 |
US7241744B2 (en) | 2007-07-10 |
EP1465654B1 (en) | 2015-02-25 |
US8178504B2 (en) | 2012-05-15 |
MY142457A (en) | 2010-11-30 |
AR037778A1 (en) | 2004-12-01 |
AU2002357143A1 (en) | 2003-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003049700A3 (en) | Growth hormone releasing hormone suplementation for treating chronically ill subjects | |
EP0935001A4 (en) | Novel vegf-like factors | |
MXPA04003944A (en) | A composition and method to alter lean body mass and bone properties in a subject. | |
WO2003023000A3 (en) | Linear dna fragments for gene expression | |
JP2017507703A (en) | Cannula, injection or infusion device, and method of using cannula or injection or infusion device | |
CN102399283B (en) | Mink growth hormone releasing hormone cDNA and application thereof | |
WO2002094997A2 (en) | Transcriptional regulation of target genes | |
Schwabe et al. | Effect of a novel nonviral gene delivery of BMP-2 on bone healing | |
EP2251350A3 (en) | RORalpha promoting the induction of Bmal1 | |
CA2349506A1 (en) | A method for selective expression of therapeutic genes by hyperthermia | |
CA2497892A1 (en) | Compositions and methods for tissue specific or inducible inhibition of gene expression | |
WO2002077161A3 (en) | Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses | |
KR20200047364A (en) | A novel polypeptide specifically binding to Human Serum Albumin and uses thereof | |
WO2004093920A3 (en) | Ghrh for use in treating chronic renal failure | |
WO2004081040A3 (en) | Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications | |
Zimmermann et al. | Evaluation of BMP-2 minicircle DNA for enhanced bone engineering and regeneration | |
Draghia-Akli et al. | Plasmid-based expression technology using growth hormone releasing hormone: a novel method for physiologically stimulating long-term growth hormone secretion | |
AU7032600A (en) | Gene treatment to enhance feed efficiency and growth rate of livestock | |
WO2002068629A3 (en) | Dna constructs for cytoplasmic and mithochondrial expression and methods of making and using same | |
CN115851775B (en) | Cas9 protein inhibitor and application thereof | |
JP2007244332A (en) | Method for imparting cyan-resistant respiratory ability to mitochondria as biological species | |
CN112972701B (en) | Polypeptide/gene co-delivery material, preparation method and application | |
CA2260754A1 (en) | Novel vegf-like factor | |
KR102410556B1 (en) | Peptide for targeting to mitochondria | |
US20050032735A1 (en) | Method for regulating the skin and hair color in a post-natal mammal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
B | Later publication of amended claims |
Free format text: 20030916 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2469310 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/005713 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002357143 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002804771 Country of ref document: EP Ref document number: 534027 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002827105X Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002804771 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |